Implantable Infusion Pump MarketThe global implantable infusion pump market is set to witness significant growth, with an expected valuation of approximately USD 485.1 million in 2022. The market is ...

Analyst Jeff Johnson from Robert W. Baird reiterated a Hold rating on Tandem Diabetes Care (TNDM – Research Report) and increased the ...

GAMMA Investing LLC increased its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Free Report) by 17.0% ...

Fintel reports that on October 4, 2024, Goldman Sachs initiated coverage of Tandem Diabetes Care (NasdaqGM:TNDM) with a ...

RBC expects 51% gross margins in 2024, with the Mobi pump launch driving long-term profitability. RBC Capital Markets initiated coverage on Tandem Diabetes Care, Inc. TNDM, a global insulin ...

slim X2 pump, to be used in the 27-country bloc to deliver Eli Lilly's Lyumjev ultra-rapid acting insulin. Before you buy stock in Tandem Diabetes Care, consider this: The Motley Fool Stock ...

Despite that, it remains bullish on Tandem's prospects ... the company's t:slim X2 pump, to be used in the 27-country bloc to deliver Eli Lilly's Lyumjev ultra-rapid acting insulin.

By integrating ultra-rapid acting insulin such as Lyumjev, which responds faster than traditional insulin, Tandem Diabetes ...

Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at ...

Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular ...